A Pharmaceopidemiological Study in Patients Who Use Symbicort Turbuhaler as Maintenance and Reliever Therapy (Symbicort SMART) Capturing Over Use and Under Use Via the General Practice Research Database.
Phase of Trial: Phase IV
Latest Information Update: 30 Nov 2010
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 30 Nov 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 30 Nov 2010 Actual initiation date changed from (Jul 2007) to (Jun 2007) as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.